Cannabis finance news

The Medical Republic: reach 23,000 GPs with exclusive Cannabiz advertising rates

by cannabiz team October 2, 2024January 13, 2025

Medicinal cannabis firms wanting to reach doctors in a TGA-compliant environment now have the perfect marketing […]

Cann Group cites positive press coverage as possible reason for share price surge

by Martin Lane September 30, 2024January 13, 2025

Montu share buy-back offer on ice as shareholders report plan to Takeovers Panel and demand independent report

by Steve Jones September 26, 2024October 25, 2024

A revolving door of senior staff: what’s behind the turbulence at Cannatrek?

by Steve Jones September 26, 2024September 26, 2024

Bioxyne forecasts doubling of revenue amid ‘$100m gummy opportunity’

by Steve Jones September 26, 2024September 26, 2024

Cultivator edges towards $500k in Birchal crowdfunding campaign

by Steve Jones September 25, 2024September 26, 2024

Montu named as customer behind ‘$28m’ gummy deal as Bioxyne resumes trading on ASX

by Steve Jones September 18, 2024September 19, 2024

Montu to offer Birchal investors up to $14m in share buy-back pay day

by Steve Jones September 12, 2024September 12, 2024

Health House for sale as parent company remains suspended from ASX

by Steve Jones September 12, 2024September 12, 2024

Byron Bay Bio set for Birchal raise as tech advancements form centrepiece of company vision

by Steve Jones September 9, 2024January 13, 2025